Navigation Links
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to Froedtert Hospital in Milwaukee
Date:3/10/2008

ATLANTA and MILWAUKEE, March 10 /PRNewswire/ -- Elekta Neuromag(R), the world-leading equipment for non-invasive measurement of brain activity using Magnetoencephalography (MEG) technology, has been ordered by Froedtert Memorial Lutheran Hospital.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

Located in the western suburbs of Milwaukee, Froedtert Hospital has played a critical role in the quality of life in Wisconsin and Northern Illinois since opening its doors in 1980 as a not-for-profit hospital. More than 800 Medical College of Wisconsin physicians and more than 4,000 staff members are dedicated to excellence in patient care, research and medical education at this premier academic medical center.

Froedtert Hospital will receive its new Elekta Neuromag MEG system in the autumn of 2008. With the MEG system from Elekta installed, neurosurgeons, neurologists and those in related fields will be able to non-invasively record human brain activity in real time, better and more accurately than ever before.

MEG technology is regarded as the most efficient method for tracking brain activity at millisecond resolution. Compared to EEG technology, MEG has uniquely accurate localization capabilities. Other technologies, for example Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), provide only anatomical or metabolic information; whereas MEG is a direct measure of neuronal electric activity. When complemented with MRI, MEG increases the ability to understand brain activity and to improve treatment of functional disorders and, in particular, epilepsy.

"We look forward to soon becoming the site of the first whole-head Magnetoencephalography lab in the state," says Elizabeth Ragalie, Director of the Neurosciences Center at Froedtert Hospital. "We intend to use the MEG in our epilepsy program as a powerful new tool for pre-su
'/>"/>

SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
2. Elekta Demonstrates Commitment to Stereotactic Innovation at EANS
3. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
4. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
5. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
6. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
7. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
8. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
9. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
10. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
11. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , DURHAM, N.C., Nov. 25 Resear...rst energy-efficient, single-treatment water purif...nanotubes to Andhra Pradesh, Minister of Rural Wat...s in Hyderabad, India today. Initial tests, perfor..., confirmed that the majority of the drinking wate...
(Date:11/25/2009)... , ,, BOCA RATON, Fla., Nov. 2...en a painful year. Not so for BodyLogicMD. The na...rt physicians specializing exclusively in medicall...e number of physicians in its network since ... in progress to add more physician-owned centers, ...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlink... is available in its catalogue: ,, Brazil Bioe..., http://www.reportlinker.com/p0165503/Brazil-Bio... ,, Brazil Bioethanol Market Analysis and Fore...vides detailed analysis and forecasts of the globa...
(Date:11/24/2009)..., HOUSTON, Nov. 24 IES...electrical and communications systems and services...rkets, announced today that its commercial busines... Torcon JV to install the electrical systems for t...lity at the U.S. Army Medical Research Institute o...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) t...arter and year ended December 31, 2008. For the...1 million and a net loss of $22.8 million. Cash a...ber 31, 2008. , , On March 27, the Company filed...h included an audit opinion with a "going concern"...
... Biomedical, Inc., announced today that it will ma... progenitor cells commercially available to the re...otent human embryonic stem cells, ArunA,s hMC line...populations of mesenchymal cells in a feeder free ...com.com/cgi-bin/prnh/20080819/CLTU003LOGO ) , ...
... Catalyst Pharmaceutical Partners, Inc. (Nasdaq: ...s, in-licenses, develops and commercializes prescr...today reported financial results for the fourth qu...lyst made significant progress in 2008," said Patr...t Pharmaceutical Partners. "During the year, we i...
Other Biology Technology:TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results 2TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results 3TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results 4TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results 5ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells 2Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 2Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 3Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 4Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 5Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 6
(Date:11/26/2009)...deer have been caught in the hunters, sights for g...n decorative. They are lethal weapons that stags c... University of York, UK, has been intrigued by the...tury and has become fascinated by the mechanical p...oration with Tomas Landete-Castillejos at the Univ...
(Date:11/26/2009)...us Aureus ) and other drug-resistant bacteria coul...otype devices have been developed to offer safe, q..., Two prototype devices have been developed: one ...ands and feet) in hospitals and public spaces wher...o shoot bacteria-killing agents into infested chro...
(Date:11/25/2009)...th Research Laboratory in the University of Haifa,...tigious Johnson & Johnson Focused Funding grant fo...amage in Parkinson,s disease. The award, which is ...vation and excellence in science, was announced in... at an event at the Hyatt Regency Hotel in New Jer...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Scientists watch as peptides control crystal growth with switches throttles and brakes 10874 1Scientists watch as peptides control crystal growth with switches throttles and brakes 10874 2Scientists watch as peptides control crystal growth with switches throttles and brakes 10874 3Reportlinker Adds U S Market for PACS and EMR 6477 1Reportlinker Adds U S Market for PACS and EMR 6477 2Reportlinker Adds U S Market for PACS and EMR 6477 3Reportlinker Adds U S Market for PACS and EMR 6477 4Reportlinker Adds U S Market for PACS and EMR 6477 5Reportlinker Adds U S Market for PACS and EMR 6477 6Reportlinker Adds U S Market for PACS and EMR 6477 7Reportlinker Adds U S Market for PACS and EMR 6477 8Reportlinker Adds U S Market for PACS and EMR 6477 9Reportlinker Adds U S Market for PACS and EMR 6477 10Reportlinker Adds U S Market for PACS and EMR 6477 11Reportlinker Adds U S Market for PACS and EMR 6477 12Reportlinker Adds U S Market for PACS and EMR 6477 13Reportlinker Adds U S Market for PACS and EMR 6477 14Reportlinker Adds U S Market for PACS and EMR 6477 15Reportlinker Adds U S Market for PACS and EMR 6477 16Reportlinker Adds U S Market for PACS and EMR 6477 17Reportlinker Adds U S Market for PACS and EMR 6477 18Reportlinker Adds U S Market for PACS and EMR 6477 19Reportlinker Adds U S Market for PACS and EMR 6477 20Reportlinker Adds U S Market for PACS and EMR 6477 21Reportlinker Adds U S Market for PACS and EMR 6477 22Reportlinker Adds U S Market for PACS and EMR 6477 23Reportlinker Adds U S Market for PACS and EMR 6477 24Reportlinker Adds U S Market for PACS and EMR 6477 25Reportlinker Adds U S Market for PACS and EMR 6477 26Reportlinker Adds U S Market for PACS and EMR 6477 27Reportlinker Adds U S Market for PACS and EMR 6477 28Reportlinker Adds U S Market for PACS and EMR 6477 29Reportlinker Adds U S Market for PACS and EMR 6477 30Reportlinker Adds U S Market for PACS and EMR 6477 31Reportlinker Adds U S Market for PACS and EMR 6477 32Reportlinker Adds U S Market for PACS and EMR 6477 33Reportlinker Adds U S Market for PACS and EMR 6477 34Reportlinker Adds U S Market for PACS and EMR 6477 35Reportlinker Adds U S Market for PACS and EMR 6477 36Reportlinker Adds U S Market for PACS and EMR 6477 37Research Yields Clues to Severe Form of Sinusitis 61963 1Research Yields Clues to Severe Form of Sinusitis 61963 2
...an. 16, 2008) -- Two major federal grants have bee...l Medical College in New York City. , Dr. Kennet... million NIH grant from the National Institute on ...effects of a school-based drug-abuse prevention pr... attending New York City middle schools. The study...
...nuary 16, 2008) The latest medications can delay ...e to reverse its devastating effects. This limitat...ers patients maintaining a good quality of life fo...oped by the Georgia Institute of Technology and Em... inexpensive test that could be administered as pa...
... most significant questions facing marine ecologis...iations in the environment are having on the dispe...en oceans to coral reefs. Previously, tracking how...vation by divers on older larvae found near the re...kton. This method did not permit divers to follow ...
Other Biology News:2 federal public health grants awarded to Weill Cornell Medical College 2Portable device quickly detects early Alzheimer's 2Portable device quickly detects early Alzheimer's 3How baby fish find a home 2
Reverse Transcriptase AMV; RNA dependent DNA polymerase from Roche Applied Science
MMLV RT from Invitrogen
Shake 'n' Stack oven - New Model from Thermo Scientific
DNA Polymerase I, E. coli from EPICENTRE Biotechnologies
Biology Products: